Fox Run Management, L.L.C. Alkermes Plc. Transaction History
Fox Run Management, L.L.C.
- $433 Million
- Q3 2024
A detailed history of Fox Run Management, L.L.C. transactions in Alkermes Plc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 12,690 shares of ALKS stock, worth $376,258. This represents 0.08% of its overall portfolio holdings.
Number of Shares
12,690
Previous 8,846
43.45%
Holding current value
$376,258
Previous $213,000
66.67%
% of portfolio
0.08%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding ALKS
# of Institutions
362Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$863 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$563 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$385 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$375 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$272 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.87B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...